Stay updated with breaking news from Tech Transfer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Attend this Lunch and Learn from noon-1 p.m. on Tuesday (Sept. 13) to meet the director and case managers and learn how the Office of Tech Transfer can help you with commercializing research.
According to a study, a single drug compound can help immune cells penetrate tumors, and cut off the tumor’s ability to burn testosterone as fuel in prostate cancer.
A single drug compound simultaneously attacks hard-to-treat prostate cancer on several fronts, according to a new study in mice and human cells.
We are pleased to announce that Ajinomatrix will be combining its data integration approach for the food and beverage industry with Hebrew University's patent-pending AI technology for modeling the relationships between recipes and taste targets licensed under Yissum, Hebrew University's Tech Transfer Company.
Ajinomatrix Licenses AI Meta-Recipe Patent & Neural Networks from Hebrew University’s Revolutionary Digital Gastronomy Laboratory (Nov 18, 2022)